Intranasal Oxytocin in Hypothalamic Obesity

NCT02849743 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Craniopharyngioma
Hypothalamic Obesity

Interventions

DRUG: Syntocinon
DRUG: Placebo (for Syntocinon)

Sponsor

Shana McCormack, MD